Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrasentan in type 2 diabetic nephropathy (China Phase 3)
CTR20140661Phase 3Suspended
- Sponsor
- AbbVie Inc.
- Start
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of atrasentan in diabetic glomerulosclerosis, sponsored by AbbVie Inc.. Started Dec 2014; status: suspended.
02
Drugs
atrasentan
03
Conditions
diabetic glomerulosclerosis
Beyond the preview
Go deeper on CTR20140661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140661.